- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lipella Pharmaceuticals Inc (LIPO)
Track today's live Lipella Pharmaceuticals (LIPO) share price, performance and key data on this page with our current OTC Markets:LIPO stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Lipella Pharmaceuticals share price on the OTC Markets exchange. Use the dropdown to switch exchange for the LIPO share price, head to our technical summary section, which provides analysis on Lipella Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Lipella Pharmaceuticals (LIPO) stock price today with other investors in the Lipella Pharmaceuticals OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:LIPO share price (ISIN: US53630L2097) to enhance your trading decisions with our free investment tools and resources.
What Is the Lipella Pharmaceuticals Inc Share Price Today?
The Lipella Pharmaceuticals share price today is 0.0004.
What Is the Stock Symbol for Lipella Pharmaceuticals Inc
The stock symbol (or 'ticker') for Lipella Pharmaceuticals Inc is "LIPO."
What Stock Exchange Does Lipella Pharmaceuticals Inc Trade On?
Lipella Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Lipella Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Lipella Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:LIPO share price (ISIN: US53630L2097) to enhance your trading decisions with our free investment tools and resources.
What Is the Lipella Pharmaceuticals Inc Share Price Today?
The Lipella Pharmaceuticals share price today is 0.0004.
What Is the Stock Symbol for Lipella Pharmaceuticals Inc
The stock symbol (or 'ticker') for Lipella Pharmaceuticals Inc is "LIPO."
What Stock Exchange Does Lipella Pharmaceuticals Inc Trade On?
Lipella Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Lipella Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Lipella Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
OTC Markets
Currency in USD
0.0004
0.0000(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0004
0.0004
52 wk Range
0.0002
0.6407
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00040.0004
52 wk Range
0.00020.6407
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIPO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Lipella Pharmaceuticals delisted from Nasdaq- Investing.com
Lipella Pharmaceuticals CEO issues letter following delisting- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
03/06/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare LIPO to Peers and Sector
Metrics to compare | LIPO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIPOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.5x | −0.3x | |
PEG Ratio | 0.00 | −0.03 | 0.00 | |
Price/Book | 0.0x | 1.7x | 2.6x | |
Price / LTM Sales | 0.0x | 137.5x | 3.1x | |
Upside (Analyst Target) | - | 144.5% | 48.5% | |
Fair Value Upside | Unlock | 7.8% | 6.3% | Unlock |
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lipella Pharmaceuticals (OTC Markets: LIPO) Share Price Today?
The Lipella Pharmaceuticals stock price today is 0.0004 USD.
What Stock Exchange Does Lipella Pharmaceuticals (LIPO) Trade On?
Lipella Pharmaceuticals is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Lipella Pharmaceuticals?
The stock symbol (also called a 'ticker') for Lipella Pharmaceuticals is "LIPO."
What Is the Current Lipella Pharmaceuticals Market Capitalisation?
As of today, Lipella Pharmaceuticals (OTC Markets: LIPO) market cap is 1.8500K USD.
What Is Lipella Pharmaceuticals's (LIPO) Earnings Per Share (TTM)?
The Lipella Pharmaceuticals EPS is currently -1.7592 (Trailing Twelve Months).
When Is the Next Lipella Pharmaceuticals Earnings Date?
Lipella Pharmaceuticals's next earnings report will be released on 02/09/2026.
Is LIPO a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lipella Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for LIPO stock is Strong Sell.
How Many Times Has Lipella Pharmaceuticals Stock Split?
Lipella Pharmaceuticals has split 1 times. (See the LIPO stock split history page for full effective split date and price information.)
What is the current trading status of Lipella Pharmaceuticals (OTC Markets: LIPO)?
As of 20/08/2026, Lipella Pharmaceuticals (LIPO) is trading at a share price of 0.0004 USD, with a previous close of 0.0004 USD. The stock has fluctuated within a day range of 0.0004 USD to 0.0004 USD, while its 52-week range spans from 0.0002 USD to 0.6407 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.